Investors Hangout Stock Message Boards Logo
  • Mailbox
  • Favorites
  • Boards
    • The Hangout
    • NASDAQ
    • NYSE
    • OTC Markets
    • All Boards
  • Whats Hot!
    • Recent Activity
    • Most Viewed Boards
    • Most Viewed Posts
    • Most Posted
    • Most Followed
    • Top Boards
    • Newest Boards
    • Newest Members
  • Blog
    • Recent Blog Posts
    • Recently Updated
    • News
    • Stocks
    • Crypto
    • Investing
    • Business
    • Markets
    • Economy
    • Real Estate
    • Personal Finance
  • Market Movers
  • Interactive Charts
  • Login - Join Now FREE!
  1. Home ›
  2. Stock Message Boards ›
  3. Stock Boards ›
  4. Generex Biotechnology Corp. (GNBTQ) Message Board

GNBT bought Veneto,an asset with a strong record o

Message Board Public Reply | Private Reply | Keep | Replies (3)                   Post New Msg
Edit Msg () | Previous | Next


Post# of 36564
(Total Views: 305)
Posted On: 06/24/2019 2:45:42 PM
Posted By: docj
Re: OrlandoJohn #4291
GNBT bought Veneto,an asset with a strong record of generating revenue from services/products ordered by docs who owned shares/units of the MSO. The docs rec'd investment income(distributions) from profit that was generated from the MSO.

Two problems:
1) The original purchase was based on revenue figures that were unsustainable over a long period. These programs have lifespans before insurance companies figure out ways to cut the reimbusement. Essentially, Veneto sold out near the top of the market.

2) The model MAY have been flawed in that some of the distributions may have been given out based on the amount of business the investors provided. It is referred to as "kickbacks" or "fee spitting" and is frowned upon and probably illegal when the business invoves federally insured patients.

So...GNBT takes Veneto, which still has value and slows/stops its business while reorganizing the legal investment paperwork. It takes time to get lot's of docs resigned with all the attorney's invoved. Now while all this is happening GNBT is adding new services and products into the MSO which SHOULD result in more growth going forward. So if they deliver on what they are expecting, things should be fine and the model more compliant moving forward. The easy money may have been made by pre-GNBT Veneto but the expanded lines of business can still add up.


(0)
(0)




Generex Biotechnology Corp. (GNBTQ) Stock Research Links


  1.  
  2.  


  3.  
  4.  
  5.  






Investors Hangout

Home

Mailbox

Message Boards

Favorites

Whats Hot

Blog

Settings

Privacy Policy

Terms and Conditions

Disclaimer

Contact Us

Whats Hot

Recent Activity

Most Viewed Boards

Most Viewed Posts

Most Posted Boards

Most Followed

Top Boards

Newest Boards

Newest Members

Investors Hangout Message Boards

Welcome To Investors Hangout

Stock Message Boards

American Stock Exchange (AMEX)

NASDAQ Stock Exchange (NASDAQ)

New York Stock Exchange (NYSE)

Penny Stocks - (OTC)

User Boards

The Hangout

Private

Global Markets

Australian Securities Exchange (ASX)

Euronext Amsterdam (AMS)

Euronext Brussels (BRU)

Euronext Lisbon (LIS)

Euronext Paris (PAR)

Foreign Exchange (FOREX)

Hong Kong Stock Exchange (HKEX)

London Stock Exchange (LSE)

Milan Stock Exchange (MLSE)

New Zealand Exchange (NZX)

Singapore Stock Exchange (SGX)

Toronto Stock Exchange (TSX)

Contact Investors Hangout

Email Us

Follow Investors Hangout

Twitter

YouTube

Facebook

Market Data powered by QuoteMedia. Copyright © 2025. Data delayed 15 minutes unless otherwise indicated (view delay times for all exchanges).
Analyst Ratings & Earnings by Zacks. RT=Real-Time, EOD=End of Day, PD=Previous Day. Terms of Use.

© 2025 Copyright Investors Hangout, LLC All Rights Reserved.

Privacy Policy |Do Not Sell My Information | Terms & Conditions | Disclaimer | Help | Contact Us